FDA.reportPublic FDA data

cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution

RxCUI
2104336
RxNorm name
cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution
Display name
cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution
Full name
cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761094Oxervatecenegermin-bkbj351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89e4bfec-d710-40ed-8885-5d13ba46b1cdcenegermin-bkbj 0.002 % Ophthamic Solution [PSN] · cenegermin-bkbj 0.02 MG/ML Ophthalmic Solution [SCD] · cenegermin-bkbj 0.002 % Ophthamic Solution [SY] · cenegermin-bkbj 20 MCG/ML Ophthamic Solution [SY]414These highlights do not include all the information needed to use OXERVATE safely and effectively. See full prescribing information for OXERVATE. OXERVATE ® (cenegermin-bkbj) ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 201820250205